Douglas Roeder Acquires 17,500 Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Director Douglas Roeder acquired 17,500 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction that occurred on Friday, March 13th. The shares were purchased at an average cost of $5.73 per share, for a total transaction of $100,275.00. Following the purchase, the director directly owned 119,731 shares in the company, valued at $686,058.63. The trade was a 17.12% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Senseonics Holdings, Inc. Common Stock Stock Performance

Shares of NASDAQ SENS opened at $6.49 on Wednesday. Senseonics Holdings, Inc. Common Stock has a 52-week low of $5.25 and a 52-week high of $15.74. The company has a quick ratio of 4.55, a current ratio of 4.83 and a debt-to-equity ratio of 0.58. The company has a market cap of $271.09 million, a P/E ratio of -3.84 and a beta of 0.90.

Analyst Ratings Changes

Several research firms have weighed in on SENS. Stifel Nicolaus set a $9.00 target price on Senseonics Holdings, Inc. Common Stock in a report on Tuesday, March 3rd. TD Cowen restated a “buy” rating on shares of Senseonics Holdings, Inc. Common Stock in a report on Thursday, January 8th. Finally, Weiss Ratings assumed coverage on Senseonics Holdings, Inc. Common Stock in a research report on Tuesday, February 17th. They set a “sell (d-)” rating on the stock. Two analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.70.

Institutional Investors Weigh In On Senseonics Holdings, Inc. Common Stock

A number of hedge funds and other institutional investors have recently made changes to their positions in SENS. Keynote Financial Services LLC boosted its stake in Senseonics Holdings, Inc. Common Stock by 1.5% in the 3rd quarter. Keynote Financial Services LLC now owns 211,350 shares of the company’s stock worth $92,000 after purchasing an additional 3,065 shares during the period. Smith Salley Wealth Management raised its stake in shares of Senseonics Holdings, Inc. Common Stock by 10.9% in the 3rd quarter. Smith Salley Wealth Management now owns 61,000 shares of the company’s stock valued at $27,000 after purchasing an additional 6,000 shares during the period. GSK plc acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 4th quarter valued at about $60,000. Townsend Asset Management Corp NC ADV bought a new stake in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at about $60,000. Finally, Sanctuary Advisors LLC acquired a new position in shares of Senseonics Holdings, Inc. Common Stock during the fourth quarter worth about $71,000. 12.36% of the stock is currently owned by institutional investors and hedge funds.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.